X-ray regulations and room design methodology vary widely across Canada. The Canadian Organization of Medical Physicists (COMP) conducted a survey in 2016/ 2017 to provide a useful snapshot of existing variations in rules and methodologies for human patient medical imaging facilities. Some jurisdictions no longer have radiation safety regulatory requirements and COMP is concerned that lack of regulatory --
oversight might erode safe practices. Harmonized standards will facilitate oversight that will ensure continued attention is given to public safety and to control workplace exposure. COMP encourages all Canadian jurisdictions to adopt the dose limits and constraints outlined in Health Canada Safety Code 35 with the codicil that the design standards be updated to those outlined in NCRP 147 and BIR 2012. under the exclusive jurisdiction of the CNSC. The CNSC issues licenses for the manufacture, acquisition, and use of radionuclides and the standards are uniformly applied across the country. The situation is different for x-ray-emitting devices with energies below 1 MeV. Federal agencies authorize the sale, lease, and importation of x-ray devices, but it is the jurisdiction of the Provinces and Territories to regulate the installation and use of medical x-ray imaging equipment. Consequently, permitted uses, occupational dose constraints and limits, and shielding design of x-ray facilities vary across the country. As many jurisdictions are attempting to reduce the legislative burden of radiation safety regulations, the Canadian Organization of Medical Physicists (COMP) conducted a survey in 2016/ 2017 to provide a useful snapshot of existing variations in rules and methodologies for human patient medical imaging facilities in order to assist jurisdictions to harmonize approaches.
| BACKGROUND
Canada has adopted the guidelines of the International Commission on Radiological Protection (ICRP) on occupational dose limits for radiation. Starting with the publication of ICRP 26 1 in 1977, estimates were given of the radiation sensitivities of various organs and tissues (w t ), and the whole-body dose was considered as the sum of doses to all organs and tissues each weighted for their radiation sensitivities.
Publication ICRP 60 (1991) 2 improved upon ICRP 26 with better data on radiation sensitivities. Equivalent dose (H R ) was defined as the absorbed dose multiplied by a radiation weighting factor (w R ) related to relative biological effect of a given type of primary radiation. For xray photons of concern here, w R = 1. Effective Dose (E) was defined as the sum of the equivalent dose to each organ or tissue weighted by the relevant radiation sensitivity. ICRP 103 (2007), 3 using new data, further refined the tissue sensitivities. The tissue weighting factors from the different ICRP reports are compared in Table 1 and it is noteworthy that these weighting factors change over time as the understanding of the effects of radiation on human biology improves.
At the time of publication for ICRP 103, the occupational limit for eyes was under review, and ICRP 118 was subsequently published recommending a lower limit for the eyes. 4 The recommended stochastic dose limits from ICRP 60, 103, and 118 are shown in Table 2 .
2.A | Dose constraints, diagnostic reference levels, and dose limits
A dose constraint is a restriction on the prospective doses to individuals that may result from a defined source of radiation, providing a basic level of protection for a population from planned exposure situations. The dose constraint is often chosen as a level of dose and do not apply to medical diagnosis or treatment. Diagnostic reference levels are similar to dose constraints, but are intended for medical exposure situations. An example of a dose constraint is shielding adjacent spaces of an x-ray room to planned occupational dose levels. And an example of a diagnostic reference level is the 75th percentile of a distribution of dose indicator values used for a T A B L E 1 Tissue Weighing Factors (w t ) from ICRP26, ICRP60, and ICRP103. The definition and handling of doses to Remainder tissues changed after ICRP26. Remainder tissues for ICRP103 are as follows: adrenals, extrathoracic region, gall bladder, heart, kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, prostate, small intestine, spleen, thymus, and uterus/cervix. specific patient population for a given diagnostic exam. A dose limit is used for the occupational exposure of individuals, and is a limit of exposure from all occupational sources. Two examples of dose limits are full body exposure limits for radiation workers and eye exposure limits mostly of concern in fluoroscopy guided interventional (FGI)
procedures. In both cases, if the annual dose limit is exceeded the individual should be prevented from receiving further occupational exposures for a year. Dose limits do not apply to patients.
2.B | Optimization
The dose limits in Table 2 were set at the limit of unacceptability in ICRP 60, where it was recommended that occupational exposure be kept as low as reasonably achievable (ALARA), taking social and economic considerations into account, in order to avoid exceeding these limits. These values were retained in ICRP 103. In the USA National
Council on Radiation Protection & Measurements (NCRP) report 147
it was recommended that the shielding design constraint should be 5 mSv per year for radiation workers and 1 mSv for the general public. 5 In the United Kingdom (UK), the National Radiological Protection board recommends that for optimization purposes the dose constraint should not exceed 30 % of the dose limit. 6 This recommendation is in line with ICRP, which also recommends an occupational dose constraint of ≤20 mSv/yr. 3 From personnel dosimetry it was found that the average dose to UK radiology technologists was 0.06 mSv/yr. As a result, the annual dose constraint of 0.3 mSv was adopted for workers in the shielding design of x-ray facilities, as this dose constraint was already being met. 6 2.C | Radiation shielding design • No information on modalities such as computed tomography (CT), mammography, and digital imaging.
• Attenuation data were not applicable to three phase or constant potential generators.
• Typical mAs workloads were no longer valid due to the use of newer high speed rare-earth film/screens.
• The use factors and occupancy factors appeared to be unrealistically high.
• Shielding was specified using half-value-layers (HVLs) of Pb or concrete required to attenuate scattered and primary radiation to designed levels, and the requirement to "add-one-HVL" was considered overly-conservative.
• The requirement to cover screws or nails with Pb tabs was questioned.
Funding and other issues, however, hampered the publication of 
4.B | Dose limits
As shown in Table 4 , many jurisdictions use the annual dose limits from SC 20A; that is, 50 mSv for x-ray workers, 1 mSv for the public, and 4 mSv for the remainder of a pregnancy following declaration. A few provinces have adopted the more recent 20 mSv for radiation workers from SC 35, and some jurisdictions have no limits due to the lack of regulations. For jurisdictions without regulations, institutions or authorities usually set their own limits as best practice, but there is a risk they might not.
4.C | Shielding of x-ray facilities
No two provinces or territories have the same standards for the shielding of x-ray facilities, as shown in more specifically define the practice of engineering as "the principles of mathematics, chemistry, physics or any related applied subject"
and Prince Edward Island has similar wording, Note 6 whereas Quebec considers the field of practice to include works using "processes of applied chemistry or physics." Note 7 In practice, most jurisdictions do not formally require an engineer's oversight for a shielding design, with the exception of Quebec and Ontario. As part of any engineering design work, field reviews are required, which include visual inspections and scatter surveys in Table 5 . Consequently, with regards to Table 6 , an engineer is not obligated to use only specific design documents permitted by regulations or accreditation agencies, but are expected to use any and all methodologies that would be considered good practice and obvious to peers performing similar design work.
As shown in Table 6 , for all provinces with regulations, except
Ontario, NCRP147 is identified as the main source of information for the design of x-ray shielding. In Ontario, assuming a radiographic detector has a certain Pb equivalency as suggested by NCRP 147 has to be approved by the x-ray inspection service. Many provinces Could be 2 mSv or lower depending on the designated regional occupational health physician. Act (2017) is in the consolidation period and not yet in force. Note 8 The Canadian Organization of Medical Physicists strongly supported the modernization of the Ontario Healing Arts Radiation Protection Act 21 and contributed as a stakeholder in the Health Quality Ontario report on this topic. 22 There is a wide range of annual dose constraints used for the design of shielding, as shown in Table 7 . For x-ray workers, where there are regulations, the range is 1 to 50 mSv, and the range for the General Public is 1 to 5 mSv. It is also interesting to note that the constraints and dose limits (Table 4 ) are often different. An appropriate and conservative approach, and one recommended by the authors of this paper who perform shielding design, is to set a shielding design goal of 1 mSv for all cases, allowing future use of adjacent spaces to change without the need to change shielding, for example, if an office fully occupied by a radiation worker becomes office space for a nonradiation worker (general public).
4.D | Radiographer occupational exposures

1990-2016
The average and median annual occupational dose for radiographic technologists in Canada are shown in Fig. 1 . The average value for 2016 is approximately 0.10 mSv/yr and the median value is zero.
Technologists working in FGI procedures, who typically experience higher occupational exposures, were not separated from technologists exclusively working in general radiography. The Canadian average is slightly higher than the UK radiographer average value of 0.06 mSv/yr. 6 It appears that the BIR recommendations to use a dose constraint of 30% of the dose limit (or 0.3 mSv) would also be applicable to Canadian practice, since this constraint level is already achieved, especially considering the measured values reported here include staff who are exposed to workplace radiation without protection from structural shielding, including technologists who work in FGI procedures.
A breakdown of radiographer occupation exposure by different dose ranges is shown in Fig. 2 An interesting discovery arising from the author correspondence for this work is that some facilities issue a single badge to FGI staff that is to be worn on top of the apron, which is common practice in the United States 23,24 but uncommon in Canada and not the practice suggested by SC35. 14 The ICRP recommends two dosimeters be worn-one above the apron at neck level and one under the protective apron for FGI work. 25 The NCRP recommends both practices but does not recommend a single dosimeter under the apron for FGI work. 24 For one set of facilities in Canada where they issue a single badge to FGI workers to be worn on top of the apron, we confirmed that from 2008 to 2016, the collar badge readings are being reported as whole-body readings (occupational dose) with the National Dose Registry. Such practice can routinely result in badge readings exceeding 20 mSv while the true occupational dose is a fraction of this. We verified that at least some of the high "occupational dose" readings in Fig. 2 distinction between diagnostic x-ray personnel and nuclear medicine personnel in terms of permissible exposure, but the latter of course are monitored under the CSNC regulations. In practice, it is the experience of these authors that x-ray radiation workers rarely exceed an occupational exposure of 1 mSv/yr, whereas a nuclear medicine radiation worker has a much higher probability of doing so.
| CONCLUSIONS
In the interests of public safety and to control workplace exposure, it would be useful for different jurisdictions in Canada to adopt a harmonized approach, by implementing uniform dose limits and con- 
